Cullinan Therapeutics is dedicated to creating new standards of care for patients. They have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Their portfolio encompasses a wide range of modalities, each with the potential to be best and/or
…More first in class.